Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Award

Cymulate Breach and Attack Simulation (BAS) Named a Gold Winner in 2024 Globee® Awards for Cybersecurity


Cymulate, the leader in security and exposure validation, announced today that it has once again been named a gold winner in the Breach and Attack Simulation (BAS) category of the 2024 Globee Awards for Cybersecurity, having been recognized with the same honor for the fifth time.

The Globee Awards acknowledge the top achievements in cybersecurity, honoring the individuals, organizations, products and initiatives safeguarding digital landscapes from emerging threats. Now in its 20th year, the award program promotes the continual advancement of the cybersecurity industry by highlighting the vendors and end-users who are making the most significant contributions. More than 500 judges from various industries and organizations worldwide participate in the judging and selection process.

"With a focus on innovation, advanced threat research and ease of use, Cymulate is dedicated to providing the automated security and exposure validation that security teams rely on to strengthen their security posture before the next attack," said Eyal Wachsman, CEO of Cymulate. "The Globee Awards are yet another industry accolade for our BAS solution, proving that we are setting a gold standard with our award-winning advanced offensive testing automation and user experience for security validation."

Cymulate BAS enables security professionals to continuously challenge, validate and optimize their security posture by safely conducting threat activities, tactics, techniques and procedures in cloud and on-premise production environments. The platform offers security teams an easy-to-use interface and out-of-the-box threat-intelligence led security assessments that are simple to deploy and manage by organizations of all maturity levels. In addition to the out-of-the-box simulations, Cymulate BAS features an open framework to create and automate custom campaigns unique to an organization's environments and security policies.

The platform is available as a standalone SaaS or an integrated offering within the Cymulate Exposure Management and Security Validation Platform for a comprehensive and scalable solution driving continuous threat exposure management (CTEM) within their organization. Cymulate BAS can also be integrated into many SIEM, SOAR, GRC, EDR and other tools via API to provide context of assessment findings and optimize existing security solutions.

Cymulate previously won a gold Globee for BAS in 2018, 2019, 2020 and 2023, and was recognized with a bronze Globee for its Extended Security Posture Management in 2022.

To learn more about Cymulate's BAS offering, visit: www.cymulate.com.

About Cymulate

Cymulate, the leader in security and exposure validation, provides the single source of truth for threat exposure and the actions required to close security gaps before attackers can exploit them. More than 500 customers worldwide rely on the Cymulate platform to baseline their security posture and strengthen cyber resilience with continuous discovery, validation, prioritization, and guided remediation of security weaknesses. Cymulate automates advanced offensive security testing to validate controls, threats, and attack paths. As an open platform, Cymulate integrates with existing security and IT infrastructure and drives the workflows of the exposure management process. For more information, visit www.cymulate.com.


These press releases may also interest you

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

at 06:07
Gotion High-tech hosted its 13th Technology Conference on May 17, unveiling its new products and new technology, including 5C ultra-fast charging G-Current battery ready for immediate mass production, high-nickel NCM cylindrical Stellary battery and...



News published on and distributed by: